These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1950278)

  • 1. [The standardization of the in-vitro tetanus toxin neutralization test on Chinese hamster ovary cells].
    Khardina AA; Amelina IP; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):21-3. PubMed ID: 1950278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells.
    Gillenius P; Jäätmaa E; Askelöf P; Granström M; Tiru M
    J Biol Stand; 1985 Jan; 13(1):61-6. PubMed ID: 4039324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trial of pertussis toxin activity in vitro on CHO cells].
    Spitsyn SV; Drobyshevskaia EI; Gureeva AA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):60-3. PubMed ID: 3630484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
    Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
    J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test.
    Souza Matos DC; Marcovistz R; Cabello PH; Georgini RA; Sakauchi D; da Silva LL
    Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):909-13. PubMed ID: 12386721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test.
    Sonobe MH; Trezena AG; Guilhen FB; Takano VL; Fratelli F; Sakauchi D; Morais JF; Prado SM; Higashi HG
    Braz J Med Biol Res; 2007 Jan; 40(1):69-76. PubMed ID: 17224998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis.
    Halperin SA; Bortolussi R; Kasina A; Wort AJ
    J Clin Microbiol; 1990 Jan; 28(1):32-8. PubMed ID: 2405012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
    BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preclinical studies of an adsorbed diphtheria-tetanus-pertussis vaccine (ADTP-vaccine) with acellular pertussis component].
    Zaĭtsev EM; Britsina MV; Bazhanova IG; Mertsalova NU; Ozeretskovskaia MN; Ermolova EV; Plekhanova NG; Mikhaĭlova NA; Kolyshkin VA; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):44-9. PubMed ID: 24605674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
    Bernstein HH; Seyferth ER
    Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.
    Marcinak JF; Ward M; Frank AL; Boyer KM; Froeschle JE; Hosbach PH
    Am J Dis Child; 1993 Mar; 147(3):290-4. PubMed ID: 8438810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.
    Meade BD; Deforest A; Edwards KM; Romani TA; Lynn F; O'Brien CH; Swartz CB; Reed GF; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):570-5. PubMed ID: 7659478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of interfering activity in serum samples in the Chinese hamster ovary pertussis serology assay.
    Østergaard E; Sørensen C; Nielsen L; Stawski G
    Clin Vaccine Immunol; 2008 Aug; 15(8):1244-7. PubMed ID: 18562565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.